Cargando…
Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10]
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758034/ https://www.ncbi.nlm.nih.gov/pubmed/29505037 http://dx.doi.org/10.1016/j.ajoc.2017.02.004 |
_version_ | 1783290935901159424 |
---|---|
author | Zafar, Sidra Burq, M.A. Iftikhar, Mustafa Ali, Azam |
author_facet | Zafar, Sidra Burq, M.A. Iftikhar, Mustafa Ali, Azam |
author_sort | Zafar, Sidra |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5758034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-57580342018-03-02 Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10] Zafar, Sidra Burq, M.A. Iftikhar, Mustafa Ali, Azam Am J Ophthalmol Case Rep Corrigendum Elsevier 2017-02-28 /pmc/articles/PMC5758034/ /pubmed/29505037 http://dx.doi.org/10.1016/j.ajoc.2017.02.004 Text en © 2016 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Corrigendum Zafar, Sidra Burq, M.A. Iftikhar, Mustafa Ali, Azam Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10] |
title | Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10] |
title_full | Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10] |
title_fullStr | Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10] |
title_full_unstemmed | Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10] |
title_short | Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10] |
title_sort | corrigendum to ‘intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [am. j. ophthalmol. case reports (4) (2016) 7–10] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758034/ https://www.ncbi.nlm.nih.gov/pubmed/29505037 http://dx.doi.org/10.1016/j.ajoc.2017.02.004 |
work_keys_str_mv | AT zafarsidra corrigendumtointravitrealranibizumabfortreatmentofchoroidalneovascularizationsecondarytoabilateralchoroidalosteomaamjophthalmolcasereports42016710 AT burqma corrigendumtointravitrealranibizumabfortreatmentofchoroidalneovascularizationsecondarytoabilateralchoroidalosteomaamjophthalmolcasereports42016710 AT iftikharmustafa corrigendumtointravitrealranibizumabfortreatmentofchoroidalneovascularizationsecondarytoabilateralchoroidalosteomaamjophthalmolcasereports42016710 AT aliazam corrigendumtointravitrealranibizumabfortreatmentofchoroidalneovascularizationsecondarytoabilateralchoroidalosteomaamjophthalmolcasereports42016710 |